Resiliva

Resiliva uses and dosage

Resiliva (Resmetirom), generic REZDIFFRA is a prescription medicine used to treat adults diagnosed with noncirrhotic nonalcoholic steatohepatitis (NASH) accompanied by moderate to advanced liver fibrosis. NASH involves the accumulation of fat in the liver, which leads to inflammation and potentially severe liver complications over time. It improves fibrosis by at least one stage with no worsening of the NAFLD activity score. Resolves NASH with no worsening of fibrosis. Resmetirom functions by reducing hepatic fat accumulation, potentially halting disease progression. It Reduces hepatic fat content, elevated liver enzymes, and fibrosis biomarkers in NASH patients. Resiliva manufactured by Everest Pharma Ltd. in Bangladesh. Resmetirom has to take orally once daily with or without food as directed by patient’s doctor. ** <100 kg, the recommended dosage is 80 mg orally once daily. ** ≥100

Resiliva side effects

The most common side effects of Resmetirom are: Diarrhea, nausea, vomiting, itching, or dizziness.

Originator brand

REZDIFFRA by Madrigal Pharmaceuticals

Made by

Everest Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.